Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 99 clinical trials
featured
Alopecia Areata (patchy hair loss)

Alopecia Areata is an autoimmune disorder that causes patches of hair loss to occur and can lead to significant emotional distress. A research study is now underway in the Miami area to

areata alopecia
  • 96 views
  • 23 Nov, 2020
  • 1 location
featured
Hair Loss Study For Men & Women

Hair Loss Study For Men & Women

  • 14638 views
  • 23 Nov, 2020
  • 1 location
featured
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata

An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata

  • 2296 views
  • 23 Nov, 2020
  • 1 location
LEAPS-NCHD Program Evaluation

local implementation support team led by the Aga Khan University. This intervention utilizes two strategies: i) the first is the implementation of the LEAPS program, led by NCHD; and ii) the second is

  • 0 views
  • 24 Apr, 2021
  • 1 location
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups

  • 39 views
  • 27 Jan, 2021
  • 1 location
AGA Biocellular Stem/Stromal Hair Regenerative Study

) and high density platelet-rich plasma concentrate (HD- PRP) as compared with adipose-derived cell-enriched SVF (AD-cSVF) + AD-tSVF and HD- PRP concentrates in treatment of androgenetic alopecia (AGA

  • 0 views
  • 28 Jan, 2021
  • 1 location
A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Central centrifugal cicatricial alopecia (CCCA) is form of scarring hair loss that predominately affects middle-aged women of African descent.1 . Clinically, the natural progression of CCCA

  • 0 views
  • 08 Jun, 2021
  • 1 location
Long-Term PF-06651600 for the Treatment of Alopecia Areata

This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia

alopecia
pf-06651600
androgenic alopecia
areata alopecia
alopecia totalis
  • 1560 views
  • 13 Jun, 2021
  • 176 locations
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

This is a global Phase 2a randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of ritlecitinib in adults aged 18 to 50 years of age with 25% scalp hair loss

alopecia
pf-06651600
areata alopecia
alopecia totalis
treatment regimen
  • 136 views
  • 13 Jun, 2021
  • 48 locations
A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA1)

This is a multi-center Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair

areata alopecia
  • 0 views
  • 21 May, 2021
  • 70 locations